Bio-Rad Laboratories Inc (FRA:BUWA)
€ 344.2 0.1 (0.03%) Market Cap: 9.42 Bil Enterprise Value: 9.20 Bil PE Ratio: 0 PB Ratio: 1.38 GF Score: 78/100

Q2 2023 Bio Rad Laboratories Inc Earnings Call Transcript

Aug 03, 2023 / 09:00PM GMT
Release Date Price: €365.2 (-0.71%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Bio-Rad Second Quarter 2023 Earnings Results Conference Call. (Operator Instructions) This call is being recorded on Thursday, August 3, 2023. I would now like to turn the conference over to Edward Chung, Head of Investor Relations. Please go ahead.

Yong Chung
Bio-Rad Laboratories, Inc. - VP of IR

Good afternoon, everyone, and thank you for joining us. Today, we will review the second quarter 2023 financial results and provide an update on key business trends for Bio-Rad. With me on the call today are Norman Schwartz, our Chief Executive Officer; Ilan Daskal, Executive Vice President and Chief Financial Officer; Andy Last, Executive Vice President and Chief Operating Officer; Simon May, President of the Life Science Group; and Dara Wright, President of the Clinical Diagnostics Group.

Before we begin our review, I would like to caution everyone that we will be making forward-looking statements about management's goals, plans and expectations, our future financial performance and other matters.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot